Modulation of Murf-1 and MAFbx expression in the myocardium by physical exercise training

1 Wilson EM Diwan A Spinale FG Mann DL. Duality of innate stress responses in cardiac injury, repair, and remodeling. J Mot Cell Cardiol 2004; 37:801–811.

2 Wagner DR Combes A McTiernan C Sanders VJ Lemster B Feldman AM. Adenosine inhibits lipopolysaccharide-induced cardiac expression of tumor necrosis factor-alpha. Circ Res 1998; 82:47–56.

3 Yokoyama T Mann DL Rossen RD Durante W Hazarika P Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 1993; 92:2303–2312.

4 Finkel MS Oddis CV Jacob TD Watkins SC Hattler BG Simmons RL. Negative inotropic effects of cytokines on the heart are mediated by nitric oxide. Science 1992; 257:387–389.

5 Krown KA Yasui K Brooker MJ Dubin AE Nguyen C Harris GL et al. TNFa receptor expression in rat cardiac myocytes: TNFa inhibition of L-type Ca²⁺ current and Ca²⁺ transients. FEBS Lett 1995; 376:24–30.

6 Bozkurt B Kribbs SB Clubb FJ Michael LH Didenko VV Hornsby PJ et al. Pathophysiologically relevant concentrations of tumor necrosis factor alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998; 97:1382–1391.

7 Janczewski AJ Kadokami T Lemster B Frye CS McTierman CF Feldman AM. Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF-α. Am J Physiol Heart Circ Physiol 2003; 284:H960–H969.

8 Li Z Bing OH Long X Robinson KG Lakatta EG. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 1997; 272:H2313–H2319.

9 Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 1999; 79:215–262.

10 Houser SR Margulies KB. Is depressed myocyte contractility centrally involved in heart failure? Circ Res 2003; 92:350–358.

11 Oie E Bjornerheim R Grogaard HK Kongshaug H Smiseth OH Attramadal H. ET-receptor antagonism, myocardial gene expression, and ventricular remodeling during CHF in rats. Am J Physiol Heart Circ Physiol 1989; 275:H868–H877.

12 Wellner M Dechend R Park JK Shagdarsuren E Al-Saadi N Kirsch T et al. Cardiac gene expression profile in rats with terminal heart failure and cachexia. Physiol Genomics 2005; 18:256–267.

13 Attaix D Combaret L Pouch MN Tailandier D. Regulation of proteolysis. Curr Opin Clin Nutr Metab Care 2001; 4:45–49.

14 Hasselgren PO Fischer JE. Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation. Ann Surg 2001; 233:9–17.

15 Mitch WE Goldberg AL. Mechanisms of muscle waisting: the role of ubiquitin-proteasome system. N Engl J Med 1996; 335:1897–1905.

16 Lecker SH. Ubiquitin-protein ligases in muscle wasting: multiple parallel pathways? Curr Opin Clin Nutr Metab Care 2004; 6:271–275.

17 Bodine SC Latres E Baumhueter S Lai VKM Nunez L Clarke BA et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001; 294:1704–1708.

18 Kedar V McDonough H Arya R Li HH Rockman HA Patterson C. Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I. Proc Natl Acad Sci U S A 2004; 101:18135–18140.

19 Centner T Yano J Kimura E McElhinny AS Pelin K Witt CC et al. Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain. J Mol Biol 2001; 306:717–726.

20 Li HH Kedar V Zhang C McDonough H Arya R Wang DZ et al. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest 2004; 114:1058–1071.

21 Tintignac LA Lagirand J Batonnet S Sirri V Leibovitch MP Leibovitch SA. Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase. J Biol Chem 2005; 280:2847–2856.

22 Schulze PC Gielen S Schuler G Hambrecht R. Chronic heart failure and skeletal muscle catabolism: effects of exercise training. Int J Cardiol 2002; 85:141–149.

23 Mann DL Reid MB. Exercise training and skeletal muscle inflammation in chronic heart failure: feeling better about fatigue. J Am Coll Cardiol 2003; 42:869–872.

24 Gielen S Adams V Möbius-Winkler S Linke A Erbs S Yu J et al. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with Chronic Heart Failure. J Am Coll Cardiol 2003; 42:861–868.

25 Linke A Adams V Schulze PC Erbs S Gielen S Fiehn E et al. Antioxidative effects of exercise training in patients with chronic heart failure. Increase in radical scavenger enzyme activity in skeletal muscle. Circulation 2005; 111:1763–1770.

26 Hambrecht R Schulze PC Gielen S Linke A Möbius-Winkler S Erbs S et al. Effects of exercise training on insulin-like growth factor-l expression in the skeletal muscle of non-cachectic patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil 2005; 12:401–416.

27 Boluyt MO Loyd AM Roth MH Randall MJ Song EF. Activation of JNK in rat heart by exercise: effect of training. Am J Physiol Heart Circ Physiol 2003; 285:H2639–H2647.

28 Diffee GM Seversen EA Stein TD Johnson JA. Microarray expression analysis of effects of exercise training: increase in atrial MLC-1 in rat ventricles. Am J Physiol Heart Circ Physiol 2002; 284:H830–H837.

29 Weisman HF Bush DE Mannisi JA Weisfeldt ML Healy B. Cellular mechanisms of myocardial infarct expansion. Circulation 1988; 78:186–201.

30 Adams V Linke A Wisloff U During C Erbs S Kränkel N et al. Myocardial expression of Murf-1 and MAFbx after induction of chronic heart failure: effect on myocardial contractility. Cardiovasc Res 2007; 73:120–129.

31 Dimmeler S Assmus B Hermann C Haendeler J Zeiher A. Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells. Circ Res 1998; 83:334–341.

32 Gomes MD Lecker SH Jagoe RT Navon A Goldberg AL. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 2001; 98:14440–14445.

33 Glass DJ. Signaling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol 2003; 5:87–90.

34 Razeghi P Baskin KK Sharma S Young ME Stepkowski S Essop MF et al. Atrophy, hypertrophy, and hypoxemia induce transcriptional regulators of the ubiquitin proteasome system in the rat heart. Biochem Biophys Res Commun 2006; 342:361–364.

35 Lynch GS Schertzer JD Ryall JG. Therapeutic approaches for muscle wasting disorders. Pharmacol Ther 2007; 113:461–487.

36 Glickman MH Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2001; 82:373–428.

37 Sandri M Carraro U Podhorska-Okolov M Rizzi C Arslan P Monti D et al. Apoptosis, DNA damage and ubiquitin expression in normal and mdx muscle fibres after exercise. FEBS Lett 1995; 373:291–295.

38 Jones SW Hill RJ Krasney PA O'Conner B Peirce N Greenhaff PL. Dissue atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass. FASEB J 2004; 18:1025–1027.

39 Kee AJ Taylor AJ Carlsson AR Sevette A Smith RC Thompson MW. IGF-1 has no effect on postexercise suppression of the ubiquitin-proteasome system in rat skeletal muscle. J Appl Physiol 2002; 92:2277–2284.

40 Diffee GM. Adaptation of cardiac contractile properties to exercise training. Exerc Sport Sci Rev 2005; 32:112–119.

41 Siu PM Bryner RW Martyn JK Alway SE. Apoptotic adaptations from exercise training in skeletal and cardiac muscles. FASEB J 2004; 18:1150–1152.

42 Li YP Chen Y John J Moylan J Jin B Mann DL et al. TNF-alpha acts via p38MAPK to stimulate expression of the ubiquitin ligase atroginl/MAFbx in skeletal muscle. FASEB J 2005; 19:362–370.

43 Li YP Chen Y Li AS Reid MB. Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes. Am J Physiol Cell Physiol 2003; 285:C806–C812.